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AbstrACt 
Objectives To identify ways of using routine hospital data 
to improve the efficiency of retrospective reviews of case 
records for identifying avoidable severe harm
Design Development and testing of thresholds and criteria 
for two indirect indicators of healthcare-related harm 
(long length of stay (LOS) and emergency readmission) to 
determine the yield of specified harms coded in Hospital 
Episode Statistics (HES).
setting Acute National Health Service hospitals in 
England.
Participants HES for acute myocardial infarction (AMI), 
bowel cancer surgery and hip replacement admissions 
from 2014 to 2015.
Interventions Case-mix-adjusted linear regression 
models were used to determine expected LOS. Different 
thresholds were examined to determine the association 
with harm. Screening criteria for readmission included 
time to readmission, length of readmission and diagnoses 
in initial admission and readmission. The association with 
harm was examined for each criterion.
results The proportions of AMI cases with a harm 
code increased from 14% among all cases to 47% if a 
threshold of three times the expected LOS was used. For 
hip replacement the respective increase was from 10% 
to 51%. However as the number of patients at these 
higher thresholds was small, the overall proportion of 
harm identified is relatively small (15%, 19%, 9% and 8% 
among AMI, urgent bowel surgery, elective bowel surgery 
and hip replacement cohorts, respectively). Selection of the 
time to readmission had an effect on the yield of harms but 
this varied with condition. At least 50% of surgical patients 
had a harm code if readmitted within 7 days compared 
with 21% of patients with AMI.
Conclusions Our approach would select a substantial 
number of patients for case record review. Many of 
these cases would contain no evidence of healthcare-
related harm. In practice, Trusts may choose how many 
reviews it is feasible to do in advance and then select 
random samples of cases that satisfy the screening 
criteria.
IntrODuCtIOn
There are two main ways avoidable severe 
harm is identified in patients in acute hospi-
tals in the National Health Service (NHS) 
in England. However, both approaches 
have shortcomings. Incident reporting 
systems depend on staff compliance while 
retrospective case record reviews (RCRR) 
requires considerable resources which 
preclude universal application to all hospital 
admissions.
An alternative approach could be for hospi-
tals to employ administrative data to screen 
records for case note review. These include 
strengths and limitations of the study
 ► Routine hospital administrative data is inexpensive 
and easy to access.
 ► Potential healthcare-related harm can be identified 
in these data by specific codes used for such harms 
for example, complications and adverse reactions 
or by using indirect indicators known to be linked 
to such harm such as long length of stay (LOS) or 
readmission.
 ► Comparing the performance of long LOS and read-
mission across four contrasting cohorts of patients 
(emergency: acute myocardial infarction; urgent: 
non-elective bowel cancer surgery; semiurgent: 
elective bowel cancer surgery; and elective: hip re-
placement) when thresholds for LOS and criteria for 
readmission are manipulated shows that sensitivity 
and positive predictive power to identify harm can 
be increased.
 ► To confirm if any harm identified in the adminis-
trative records is healthcare-related, retrospective 
case record review is required.
 ► The approach would identify potential health-
care-related harm in large numbers of cases. A 
selection process for those going forward to case 
record review would be required.
 o
n
 28 June 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-025372 on 21 June 2019. Downloaded from 
2 Hogan H, et al. BMJ Open 2019;9:e025372. doi:10.1136/bmjopen-2018-025372
Open access 
codes for healthcare-related harm ('direct' indicators 
of harm) such as ‘complications and adverse events’ or 
‘pulmonary embolism after a surgical procedure’. In 
theory, all harm should be recorded though the complete-
ness of recording is doubtful. In addition, the data will 
not distinguish between levels of severity so instances of 
severe harm cannot be distinguished from lesser forms. 
There has been no recent estimation of the completeness 
of reporting of harm in administrative data, but a histor-
ical (1999–2003) comparison with Australia suggested 
under-reporting: 2.2% of all NHS admissions compared 
with 4.75% in Australia.1 2
Administrative data also offers the possibility of 
using two 'indirect' indicators that reflect the poten-
tial consequences of healthcare-related harm: longer 
than expected length of stay (LOS) and unplanned 
readmission. Such indicators might be used to identify 
those patients in whom it is likely harm has occurred 
even if it had not been recorded. In this way the detec-
tion or yield of harm could be enhanced. Support for 
such an approach comes from RCRR studies that have 
shown adverse events are associated with longer LOS,3–5 
though the direction of causality is unclear as a longer 
stay increases the risk of an error in care and subsequent 
harm.6 7 Similarly, a high rate of unplanned readmis-
sions has been shown to be associated with harm having 
occurred.8–10
Our aim was to identify ways of using routine hospital 
data to improve the efficiency of retrospective reviews of 
case records for identifying those patients who suffered 
avoidable severe harm. In this paper we focus on exploring 
the potential use of two indirect measures (long lengths 
of stay and early unplanned readmissions) in patients 
with one of four tracer conditions (acute myocardial 
infarction (AMI), bowel cancer surgery (elective and 
emergency) and hip replacement). These were selected 
to represent elective, urgent and emergency admissions 
for medical and surgical reasons.
With lengths of stay we have evaluated different thresh-
olds for defining a long stay; while with early readmis-
sions we have assessed a range of criteria. To evaluate 
different thresholds we assessed how they are associated 
with the presence of direct indicators of harm coded 
within the electronic care records. We then used this 
to understand the resource implications for choosing 
different screening criteria. Our specific analyses, there-
fore, focused on:
 ► The relationships between direct indicators of harm 
and:
 – Long lengths of stay.
 – The time between a patient is discharged from hos-
pital and readmitted as an emergency.
 – The length of a readmission spell.
 ► How the presence of a direct indicator of harm affects 
the chances of a subsequent readmission.
 ► Primary diagnoses on readmission that reflect poten-
tial harm.
MethOD
Data
For this analysis we used hospital administrative data as 
reported in Hospital Episode Statistics (HES) for the 
2014–2015 financial year. Diagnosis and procedure codes 
are based on the International Statistical Classification 
of Diseases and Related Health Problems, 10th Revision 
(ICD-10) and the Office of Population Censuses and 
Surveys (OPCS) Classification of Interventions and Proce-
dures, version 4 (OPCS-4). There are 20 diagnostic fields 
per episode: a primary diagnosis and up to 19 secondary 
diagnoses.
Categorising direct indicators of harm
A set of ICD-10 codes were selected as direct indicators 
of harm. These included complications and adverse reac-
tions (T80-88; Y40-84) plus others identified from the 
literature,11–13 or through consultation with clinicians 
and clinical coders and other sources of guidance.14 15 
Direct indicators of harm were divided into eight groups: 
complications and adverse reactions; thromboembolism; 
pneumonia; pressure sores; urinary tract infections; falls; 
fractures; post-procedural complications. Further details 
on these definitions are shown in online supplemen-
tary appendix 1.
selection of patient cohorts
Given that the approach to using direct or indirect indi-
cators might vary by the type of admission and condition, 
we selected four examples that represented both medical 
and surgical conditions and the urgency of the admis-
sion: (1) emergency: AMI; (2) urgent: non-elective bowel 
cancer surgery; (3) semiurgent: elective bowel cancer 
surgery; and (4) elective: hip replacement. A full list of 
ICD-10 and OPCS-4 codes for defining these cohorts is 
supplied in online supplementary appendix 2. Cohorts 
were restricted to adults (over 17 years), their first admis-
sions in 2014–2015 to an acute NHS hospital in England 
for the relevant condition or surgery, and discharged 
alive. Admissions excluded day cases or regular day or 
night attenders.
evaluating thresholds for unexpected long LOs
LOS was measured as the time between admission and 
discharge, ignoring transfers to other hospitals. The 
expected LOS of each patient was estimated using a 
linear regression model that controlled for age, sex, 
comorbidities, deprivation and emergency admissions in 
the previous 12 months. Comorbidities were measured 
using the Charlson Score and deprivation by quintiles of 
the Index of Multiple Deprivation (IMD). The expected 
LOS was estimated for each of the patient cohorts in 
2013–2014 and the parameter estimates applied to the 
2014–2015 population.
Thresholds for long lengths of stay were defined as 
multiples of the expected values, specifically two, three, 
four and five times. For each threshold, we investigated 
the association with the direct indicators of harm using a 
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linear regression model adjusting for age, sex, Charlson 
Score, IMD and number of emergency admissions in the 
previous year. We then evaluated the impact of different 
thresholds on the number of patient records that each 
trust would have to review in order to find instances of 
harm (positive predictive value; PPV) and the proportion 
of patients with harms reported in the spell that would be 
selected (sensitivity).
unplanned readmission
Patients in each cohort were identified as having an 
unplanned readmission if their subsequent admission 
was an emergency and occurred either in 2014–2015 
or 2015–2016. Screening criteria for readmissions were 
derived from combinations of:
 ► Time to readmission.
 ► Harm reported in the first episode of the readmission 
spell.
 ► Harm reported in the initial admission (present either 
in second or subsequent episodes).
 ► Primary diagnosis on readmission.
 ► Length of the readmission spell.
The relevance of the primary diagnosis on readmis-
sion to harm having occurred in the previous admission 
was determined by expert clinical review. The reviewers 
judged whether the primary diagnosis codes used in the 
dataset could represent healthcare-related harm. This 
was done for each cohort to allow for differences types of 
harm between the four cohorts (eg, conditions that are 
relevant for the hip replacement cohort may not be rele-
vant for the AMI cohort).
As with lengths of stay, different options were evaluated 
in terms of proportions of case notes to be reviewed, and 
the sensitivity and positive predicted value associated with 
the occurrence of direct indicators of harm.
Patient involvement
There were two patients on the steering group for this 
study. One was recruited through a local hospital patient 
reference group and the other was a patient advisor for 
a charity auditing the care of acutely ill patients, who 
was recruited through contact with the charity. Both 
had experience of family illness and in the case of one 
representative, a family member who had experienced 
a healthcare-related harm. The two patient representa-
tives contributed, through discussion at meetings, to the 
design of the study and suggested a range of possible 
harms that the study could look at. They also provided 
helpful input as to how study results might be effectively 
communicated to wider audiences.
resuLts
Mean age was similar across the patient cohorts (68–70 
years) and each cohort had similar distribution of 
socio-economic status (table 1). There were differences in 
sex: men made up 66% of the AMI cohort but only 40% of 
the elective hip replacements. There were also differences 
in comorbidity: 45% of emergency bowel cancer patients 
had Charlson scores of four or more compared with 5% 
of patients receiving elective hip replacement.
What is the relationship between long lengths of stay and 
direct indicators of harm?
The median LOS differed between cohorts (table 2) and 
the distribution was highly positively skewed. The preva-
lence of harm increased with LOS (figure 1). For example, 
94% of emergency bowel surgery patients staying longer 
than 50 days had experienced harm compared with 16% 
in those who stayed 5–9 days. Linear regression analysis 
found that nearly all categories of harm were signifi-
cantly positively associated with LOS: some exceptions 
being fractures in emergency bowel cancer patients and 
hospital-acquired infections in all bowel cancer patients 
(online supplementary appendix 3, table 3.1).
What are the resource implications for choosing different 
screening criteria derived from LOs?
The impacts of different LOS thresholds on the numbers 
of patient notes that would be selected and on the sensi-
tivity of detecting harm are shown in table 3.
Of all the patients with a direct indicator of harm, 
the proportion included in these subgroups (the sensi-
tivity) decreases as the threshold rises, from 56% to 15%. 
At the same time, the PPV (the number of cases identi-
fied in each threshold that would actually have a harm 
code) increases. For example, for hip replacement the 
value rises from 10% among all patients to 51% for those 
staying three times longer than expected.
What is the relationship between the presence of a direct 
indicator of harm and time to emergency readmission?
Rates of readmission within 7 days for AMI and bowel 
surgery (6%–7%) are notably higher than for hip replace-
ment (2.6%) (table 2). Approximately half of readmis-
sions within 28 days occur within the first 7 days. More 
than half the surgical patients readmitted within 7 days 
had a direct indicator of harm compared with 21% in the 
AMI cohort (figure 2). With bowel surgery cases, these 
proportions decline as time to readmission increases but 
for hip replacement patients, the decline is only after 28 
days and for AMI patients there is no association with 
time to readmission. This pattern among the surgical 
cohorts is specifically due to declines in ‘complications 
and adverse reactions’ which constitutes approximately 
65% of harm across these groups in contrast to the AMI 
cohort where only 25% are ‘complications and adverse 
reactions’.
how does the presence of a direct indicator of harm affect the 
chances of a subsequent emergency readmission?
For individuals who have a direct indicator of harm 
reported in the initial spell, the 7 day readmission rates 
are higher than the overall 7 day rates for each cohort 
except those undergoing urgent bowel cancer surgery 
(table 4). After adjusting for age and likelihood of read-
mission (using Patients at Risk of Re-admission within 30 
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days Score16), the time to readmission was only related to 
the record of a direct indicator of harm in the initial spell 
for the AMI cohort (excluding cases where there was a 
direct indicator of harm reported in both the initial spell 
and the readmission).
Table 1 Patient cohort characteristics
Acute myocardial 
infarction Urgent bowel surgery
Elective 
bowel surgery Hip replacement
N % N % N % N %
Sex
  Male 39 887 66 1637 52 9856 58 21 206 40
  Female 20 299 34 1490 48 7245 42 31 532 60
Age group (years)
  <54 11 017 18 471 15 1849 11 6651 13
  55–64 12 504 21 533 17 3567 21 10 622 20
  65–74 13 935 23 801 26 5757 34 18 345 35
  75–84 14 029 23 951 30 4839 28 14 437 27
  >85 8701 14 371 12 1089 6 2683 5
Charlson score
  0 24 299 40 1037 33 8286 48 34 203 65
  1 9448 16 203 6 1739 10 4776 9
  2 10 597 18 307 10 2174 13 8135 15
  3 6483 11 166 5 951 6 3238 6
  4+ 9359 16 1414 45 3951 23 2386 5
IMD quintiles
  1 (least deprived) 13 148 22 551 18 2489 15 7203 14
  2 12 273 21 591 19 2975 18 9222 18
  3 12 129 20 678 22 3699 22 11 380 22
  4 11 621 20 684 22 3959 23 12 326 24
  5 (most deprived) 10 258 17 588 19 3815 23 11 811 23
Admission in previous year 13 470 22 980 31 4020 24 5221 10
Direct indicator of harm 
present during the hospital 
spell
8348 14 1080 35 4479 26 5317 10
Total 60 186 3127 17 101 52 738
Hospital Episode Statistics data ©2017, reused with the permission of the Health & Social Care Information Centre. All rights reserved.
IMD, Index of Multiple Deprivation.
Table 2 Median and average lengths of stay and readmissions by condition
Total 
number of 
patients in 
cohort
Lengths of stay
Readmissions within 
7 days
Readmissions within 
28 days
Median 
(days)
Mean 
(days)
Min 
(days)
Max 
(days)
Number of 
readmissions Rate
Number of 
readmissions Rate
Acute myocardial infarction 60 186 4 6.5 0 412 4072 6.8% 8149 13.5%
Emergency bowel cancer 
surgery
3127 13 17.4 0 207 202 6.5% 445 14.2%
Elective bowel cancer surgery 17 101 7 9.7 0 235 1086 6.4% 2057 12.0%
Elective hip replacement surgery 52 738 4 4.8 0 174 1344 2.6% 2776 5.3%
Hospital Episode Statistics data ©2017, reused with the permission of the Health & Social Care Information Centre. All rights reserved.
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how is the presence of a direct indicator of harm related to 
the length of a readmission spell?
The proportion being readmitted for more than 3 days 
varied by cohort: bowel surgery over 50%, AMI 44%, hip 
replacement 32%. The latter group have more patients 
who stay for less than a day (32% compared with 13% to 
17% for the other cohorts). 44% of these readmissions 
are for conditions reported as 'other soft tissue disor-
ders' and they also include all patients with a primary 
diagnosis of 'phlebitis and thrombophlebitis' (including 
deep vein thrombosis). The latter represent cases where 
patients are discharged quickly after the readmission to 
manage the condition in the community. Direct indica-
tors of harm are significantly more prevalent when the 
readmission LOS is longer than 3 days (table 5) (p<0.001 
for each cohort).
In how many readmissions is a potential harm suggested by 
the primary diagnosis?
Just over half of readmissions within 7 days for the AMI 
cohort were admitted with a primary diagnosis that was 
judged by expert review to be potentially related to harm 
(table 6). This compares with much higher proportions 
among the other cohorts, with nearly 99% of the hip 
surgery cohort having a diagnosis that could be poten-
tially related to harm among that group (more details in 
Figure 1 Prevalence of harm by length of stay. AMI, acute 
myocardial infarction.
Table 3 Impact of different ‘longer than expected LOS’ thresholds on (1) the proportion of patients selected and (2) the 
sensitivity and positive predictive value (PPV) associated with detecting a direct indicator of harm
Threshold All cases
Longer than 
expected
Two x longer than 
expected
Three x longer than 
expected
Acute myocardial infarction
  % selected (n) 100 (60 186) 28 (17 072) 9 (5664) 4 (2618)
  Sensitivity 100% 56% 27% 15%
  PPV 14% 27% 40% 47%
Urgent bowel surgery
  % selected (n) 100 (3127) 58 (1806) 20 (631) 9 (270)
  Sensitivity 100% 81% 39% 19%
  PPV 35% 48% 66% 74%
Elective bowel surgery
  % selected (n) 100 (17 101) 26 (4420) 7 (1163) 3 (468)
  Sensitivity 100% 59% 21% 9%
  PPV 26% 60% 82% 88%
Hip replacement
  % selected (n) 100 (52 738) 31 (16 528) 5 (2516) 2 (835)
  Sensitivity 100% 60% 20% 8%
  PPV 10% 19% 41% 51%
Hospital Episode Statistics data ©2017, reused with the permission of the Health & Social Care Information Centre. All rights reserved.
Figure 2 Proportions of cases with direct indicators of harm 
reported in the first episode of the readmission spell by time 
to readmission. AMI, acute myocardial infarction.
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online supplementary appendix 3, table 3.2). There were 
no significant differences in the proportions within 7 days 
from 8 to 28 days among the surgical cohorts. However, 
there are significant reductions in proportions among 
elective bowel surgery readmissions that occur after 28 
days (p<0.001). Among the AMI cohort, the proportion 
among the earlier readmissions (50.9%) is significantly 
higher than among the later readmissions (p<0.001).
What are the resource implications for choosing different 
screening criteria derived from emergency readmissions?
Choices of criteria against which to select case records 
for review will depend on a trade-off between numbers 
of cases selected and proportion of harm that is found. 
table 7 shows the outcomes of different criteria using 
28 day readmissions as a baseline against which to compare 
proportions of notes selected and sensitivities. With the 
hip surgery and elective bowel replacement cohorts, 
given the majority of the primary diagnoses on readmis-
sion are associated with harm having occurred (table 7), 
restricting selection to these primary diagnoses (scenario 
C) makes little difference. Further limiting selection to 
cases where readmission lengths of stay exceed 3 days will 
reduce the number of case records for review by 50% or 
more but will correspond to larger reductions in sensi-
tivity (comparing scenario E with scenario C). Including 
any cases where direct indicators of harm are present, 
regardless of LOS and primary diagnosis will increase the 
PPV at the expense of having a larger proportion of notes 
to review.
DIsCussIOn
Main findings
It is possible to derive criteria from hospital administra-
tive data to select case records in order to find cases of 
severe hospital-related harm. Our findings suggest that 
adopting screening rules based on two indirect indica-
tors (long lengths of stay and early readmission) has the 
potential to improve the targeting of case record reviews. 
The precise scale of any improvements is unclear until 
selection criteria have been tested against the outcomes 
of such reviews.
The selection of LOS thresholds for screening could 
have a significant impact on the yield of cases of harm. For 
Table 4 Seven-day readmission proportions for patients with a direct indicator of harm in the second or subsequent episode 
of the initial spell
A direct indicator of harm in the second or 
subsequent episode of the initial spell
Overall 7 day 
readmission rate
P value associated 
with the presence 
of direct harm
Present
Number of 
patients
Number 
readmitted
Proportion 
readmitted within 
7 days
Acute myocardial infarction 2569 218 8.5% 6.8% <0.001
Urgent bowel surgery 393 24 6.1% 6.5% 0.76
Elective bowel surgery 528 42 8.0% 6.4% 0.12
Hip replacement 150 8 5.3% 2.6% 0.06
Hospital Episode Statistics data ©2017, reused with the permission of the Health & Social Care Information Centre. All rights reserved.
Table 5 Proportion of direct indicators of harm by length of readmission spell for readmissions within 7 days
Length of 
stay (days)
Acute myocardial infarction Bowel surgery Hip replacement
Number of 
readmissions
Proportion with direct 
indicator of harm 
(95% CI)
Number of 
readmissions
Proportion with direct 
indicator of harm 
(95% CI)
Number of 
readmissions
Proportion with direct 
indicator of harm 
(95% CI)
0 560 14.1% (11.2% to 17.0%) 211 62.6% (56.1% to 
69.1%)
427 34.7% (30.2% to 39.2%)
1 852 12.4% (10.2% to 14.6%) 158 50.0% (42.2% to 
57.8%)
248 49.2% (43.0% to 55.4%)
2 492 13.8% (10.8% to 16.9%) 123 61.0% (52.4% to 
69.6%)
127 48.8% (40.1% to 57.5%)
3 376 19.9% (15.9% to 23.9%) 127 53.5% (44.8% to 
62.2%)
112 50.0% (40.7% to 59.3%)
>3 1792 29.6% (27.5% to 31.7%) 669 68.6% (65.1% to 
72.1%)
430 64.2% (60.0% to 68.8%)
Hospital Episode Statistics data ©2017, reused with the permission of the Health & Social Care Information Centre. All rights reserved.
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example, over half those who stayed at least three times 
longer than expected had a direct indicator of harm. The 
PPV of the screen increases across the thresholds, such 
that the number of cases identified as having a direct 
indicator of harm as a proportion of all cases examined 
increases. By manipulating LOS threshold, choices can 
be made in relation to the trade-off between the number 
of cases that will actually have a harm code present at that 
threshold and the proportion of all the harm that will be 
found if only those cases are investigated.
Table 6 Proportions of patients readmitted with a primary diagnosis that is potentially related to harm
Cohort
Numbers with potential harm-related primary diagnosis
Readmissions within 7 days
Readmissions between 8 and 
28 days Readmissions after 28 days
n % (95% CI) n % (95% CI) n % (95% CI)
AMI 2071 50.9 (49.4 to 52.4) 1802 44.2 (42.7 to 45.7) 5024 43.6 (42.7 to 44.5)
Urgent bowel surgery 169 83.7 (78.6 to 88.8) 204 84.0 (79.3 to 88.6) 432 82.1 (78.9 to 85.4)
Elective bowel surgery 1019 93.8 (92.4 to 95.3) 915 94.2 (92.8 to 95.7) 1807 90.2 (88.9 to 91.5)
Hip replacement 1325 98.6 (98.0 to 99.2) 1417 99.0 (98.5 to 99.5) 5195 98.0 (97.6 to 98.4)
Hospital Episode Statistics data ©2017, reused with the permission of the Health & Social Care Information Centre. All rights 
reserved.
AMI, acute myocardial infarction.
Table 7 Implications of different scenarios for selecting case notes for readmitted patients in terms of the proportion of 28 day 
readmissions selected and the sensitivity and positive predictive value (PPV) associated with detecting a direct indicator of 
harm occurring within 28 days
Scenario
A B C D E F
All patients 
readmitted 
within 28 days
All patients 
readmitted 
within 7 days
7 day 
readmissions: 
only primary 
diagnoses 
associated with 
potential harm
7 day 
readmissions: 
primary diagnoses 
associated with 
potential harm 
or other reported 
direct indicators 
of harm
7 day readmissions: 
primary diagnoses 
associated 
with potential 
harm if length 
of readmission 
spell>three days
7 day readmissions: 
primary diagnoses 
associated 
with potential 
harm if length 
of readmission 
spell>three days, 
or other reported 
direct indicators of 
harm regardless of 
length of stay
Acute myocardial infarction
  % selected (n)* 100 (8149) 50 (4072) 25 (2071) 28 (2313) 13 (1084) 19 (1544)
  Sensitivity† 100% 51% 36% 51% 24% 51%
  PPV‡ 21% 21% 30% 37% 37% 56%
Urgent bowel surgery
  % selected (n)* 100 (445) 45 (202) 38 (169) 41 (181) 18 (81) 32 (141)
  Sensitivity 100% 50% 44% 50% 22% 50%
  PPV 49% 53% 57% 60% 59% 77%
Elective bowel surgery
  % selected (n)* 100 (2057) 53 (1086) 50 (1019) 50 (1038) 26 (533) 41 (849)
  Sensitivity 100% 58% 57% 58% 32% 58%
  PPV 59% 65% 67% 68% 73% 83%
Hip replacement
  % selected (n)* 100 (2776) 48 (1344) 48 (1325) 48 (1330) 15 (420) 29 (812)
  Sensitivity 100% 48% 48% 48% 20% 48%
  PPV 50% 49% 50% 50% 65% 82%
*Proportions are of all readmissions within 28 days.
†Proportion of direct indicators of harm occurring in readmissions within 28 days.
‡Proportion of selected cases that have a direct indicator of harm.
Hospital Episode Statistics data ©2017, reused with the permission of the Health & Social Care Information Centre. All rights reserved.
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Selection of the time to readmission has an effect on the 
yield of potential cases of harm but it varies by condition. 
At least 50% or more of the surgical patients had a direct 
indicator of harm if readmitted within 7 days, compared 
with 21% in the AMI cohort. With bowel surgery cases, 
these proportions decline as time to readmission 
increases but for hip replacement patients, the decline 
is only after 28 days and for patients with AMI there is no 
association with time to readmission. This suggests that 
the sampling window for the latter two conditions could 
be extended to 28 days without significant impact, with 
the added benefit of increasing the number of patients in 
the hip replacement cohort where there are relatively few 
readmissions. The lack of relationships between a harm 
code found in the initial admission with time to readmis-
sion suggests that the occurrence of harms in the initial 
episode may not be useful as a criterion for selecting case 
records, except, perhaps, for patients with AMI. However, 
because we were not able to identify individuals who 
had died outside hospital soon after the initial spell this 
analysis may underestimate subsequent outcomes after 
discharge following a harm.
For primary diagnoses on readmission deemed to 
be potentially associated with harm, there were higher 
frequencies among the surgical cohorts with between 80% 
and 100% of readmission primary diagnoses identified by 
clinical reviewers being potentially associated with harm. 
For the AMI cohort, the corresponding proportion was 
around 50%. This suggests that the nature of the primary 
readmission diagnosis can be useful as a further criterion 
for selecting case records and this approach would have 
the greatest impact on the AMI cohort.
Our assessments of thresholds used PPVs and sensitivity 
as we were interested in the value of case note review in 
revealing a harm and an indication of how effective they 
are at detecting all harms that may have occurred. We 
could also have used specificity and negative predictive 
values, but considered them less useful in this context.
Other literature
Previous RCRR studies estimated that the proportion 
of inpatients with an adverse event ranged from 3.8% 
to 16.6%.17 Across the four cohorts, we found higher 
proportions of harm codes. However, the conditions 
we studied were chosen to highlight different admis-
sion types and were not representative of all conditions. 
Similar rates of harm in bowel cancer patients (between 
20% and 40%) have been found in previous studies.18 A 
recent Dutch study found a higher proportion of harm in 
patients admitted with AMI, between 13.3% and 29.9%.19 
The harm in this study was found using an audit tool to 
screen electronic patient records which could account for 
a greater proportion of harm being uncovered. National 
clinical audits suggest that the rate of complications after 
percutaneous coronary interventions is around 9% in 
England,20 and after total hip replacement are about 1% 
for infection and venous thromboembolism and 3%–4% 
for dislocation.21 This is consistent with the lower inci-
dence of harm that we found in this group.
Our study is the first to look at the relationships between 
different LOS thresholds and a variety readmission char-
acteristics and coded harm in hospital administrative 
records in the UK. The Dutch have used a threshold 
based indicator, unexpectedly long LOS (UL-LOS), 
defined as the percentage of clinically admitted patients 
with an actual hospital stay that is more than 50% longer 
than expected, as a generic indicator of hospital safety 
for a number of years.22 Cihangir et al23 found a signifi-
cant positive correlation between UL-LOS and another 
indicator of potentially poor quality care, the hospital 
standardised mortality ratio (r=0.44, p<0.001) in hospital 
administrative data from two-thirds of Dutch hospitals. 
In a small, single site validation study the authors found 
that in 85 out of 191 patients with colorectal cancer with 
UL-LOS, 43 (51%) had one or more adverse events, 
compared with 9% (4 out of 44) in the non-unexpected 
long LOS group.24
Limitations
There are a number of limitations to be considered 
when interpreting our findings. First, our estimates of 
harm, based on our inclusive approach, are inflated by 
an element of double counting when the same harms 
are coded under more than one of the harm categories. 
This inflation is compounded by the fact that we inevi-
tably include a number of conditions that were present 
on admission without the routine application of 'present 
on admission’ codes. Harm codes such as pneumonia or 
urinary tract infection, which occur more commonly in 
emergency medical patients, are also more difficult to 
attribute to healthcare-related processes. It is also known 
that hospitals vary in the way they use complication and 
adverse reaction codes which has the potential to intro-
duce further bias in measurement.1
Second, one of the main limitations of developing 
screening approaches is the accuracy and completeness 
of the routine data.1 25 This limitation is particularly 
important to consider in this study which used harm 
codes for the internal validation of indirect indicators of 
harm derived from the same routine hospital administra-
tive data source. As our approach to harm code defini-
tions was inclusive in an attempt to increase sensitivity, 
it is likely that our estimates are inflated which may have 
biased assessment of the performance of indirect indica-
tors as screening tools.
Third, to assess the feasibility of using indirect indi-
cators to detect cases of harm, we have relied on direct 
indicators. However, we cannot know the relationship 
with other types of harm that are not so easily identifiable 
within routine data, and whether approaches that would 
work for the detection of harm codes we identified would 
work more generally. Our analytic approach can indi-
cate that a patient may have experienced harm and the 
patterns of harm among groups of patients with differing 
conditions and across an organisation but it cannot 
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confirm if that harm was healthcare-related, its severity 
or its avoidability without recourse to case record review.
Finally, not all long lengths of stay reflect a patient’s 
acute care needs as there may be several days when a 
patient is awaiting discharge. However, it has not been 
possible to distinguish these from the data.
Implications
Screening for harm using routine data allows large 
numbers of records to be rapidly processed with minimal 
resources required. The Global Trigger Tool has also 
been developed as a harm screening tool.26 However 
using this tool to identify triggers linked to harm, case 
records need to be individually screened, which is usually 
done manually creating a more resource intense process. 
Our approach to screening using long lengths of stay or 
early readmissions would identify a substantial number 
of patients for case record review if extended across 
all patients. In 2014–2015, there were approximately 
16 million admissions to all NHS acute trusts in England,27 
yet the cohorts we included in this analysis comprised less 
than 1%. If a threshold of twice the expected LOS was 
used for screening, we estimate this would have resulted 
in 9974 case record reviews in 2014–2015 across the four 
cohorts, which equates to about 70 per trust. If we assume 
a similar LOS distribution across all hospital admissions, 
this scales up to around 7000 reviews per year in an 
average sized trust. Furthermore, having increased the 
sensitivity of the screening process at the expense of spec-
ificity, many of these cases would contain no evidence of 
healthcare-related harm.
In practice, therefore, this suggests that one approach 
might be for Trusts to decide how many reviews they are 
going to do in advance and then select random samples 
of cases that satisfy the screening criteria. Consideration 
of how to adapt or create algorithms applicable to wider 
patient populations would also be required.
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